AVGO has recovered the ground lost during last week's consolidation, with the stock closing at $422.01 — up 2.7% on the week and back within striking distance of the analyst target cluster sitting in the $480–$545 range.
The turnaround is notable given where the previous note left off. A week ago, Broadcom was pulling back 2% on a cost-to-borrow spike and mild options caution. That picture has shifted. Cost to borrow has collapsed — from a mid-week reading near 0.58% to just 0.20%, a 65% drop over seven days and back to some of the lowest levels of the past month. That spike was transient noise, not a structural tightening. Borrow availability remains entirely unconstrained, with the lending pool effectively open — no pressure building on that front. Short interest is similarly benign: at 1.1% of free float, it edged down 3.4% on the week. This is not a stock with a meaningful short camp.
Options positioning is steady rather than defensive. The put/call ratio is running at 1.16, roughly in line with its 20-day average of 1.14 and only half a standard deviation above it. The 52-week range runs from 0.89 to 1.23, so the current reading is firmly in the middle — investors are not rushing to hedge into June 3. The ORTEX short score has drifted slightly lower over the past two weeks, from 29.8 to 29.6, and the 79th-percentile short-score rank reflects a stock where bears have not increased conviction. Overall, positioning looks neutral to mildly cautious, not charged.
The Street is the most interesting angle this week. Analyst targets have moved sharply higher across multiple firms in the past ten days. Wells Fargo lifted to $545, TD Cowen moved to $500, Citigroup raised to $500, and UBS bumped to $490 — all maintaining positive ratings. The mean target now sits at $480, implying around 14% upside to the current price. That consensus has firmed materially from where targets were sitting in mid-April, when Wells Fargo was still at $430. The bull case centres on Broadcom's embedded role in hyperscaler AI infrastructure, strategic partnerships with Google and Anthropic, and durable software revenue from the VMware integration. Bears flag the semiconductor cycle's inherent volatility, export-control risk, and a valuation that is anything but cheap: PE sits at 29.9x, EV/EBITDA at 23.7x, and price-to-book at 15x. The dividend score ranks in the 98th percentile, which adds a quality anchor, but EPS forward growth lags — ranked in just the 25th percentile on 12-month forward YoY increase, a potential friction point given the premium multiple.
Peers have had a significantly stronger week than AVGO. MRVL gained 23% over the past seven days, ALAB surged 48%, and CRDO climbed 42%. Broadcom's 2.7% weekly gain looks subdued against that backdrop, though the disparity partly reflects AVGO's far larger base and the fact it already ran hard through May following the analyst upgrade wave. NVDA, by contrast, dipped 3.4% on the week — the pair diverging as AVGO found support while NVDA consolidates.
The June 3 print is the focal point. Earnings history shows a mixed short-term reaction: the April 2026 report produced a 1.1% one-day decline before a 2.9% five-day recovery, while the March 2026 result delivered a 6% pop on the day and an 8.8% five-day gain. The previous quarterly print saw a 3.3% one-day drop followed by further weakness. With the stock trading roughly 14% below the Street's mean target and borrow conditions entirely relaxed, the setup into next Tuesday is less about whether shorts are pressing and more about whether the AI infrastructure narrative can be backed by forward guidance that justifies the premium the market is paying.
See the live data behind this article on ORTEX.
Open AVGO on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
